AVTR logo

Avantor Inc. (AVTR)

$9.16

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AVTR

Market cap

$6.25B

EPS

-0.81

P/E ratio

--

Price to sales

0.84

Dividend yield

--

Beta

0.970692

Price on AVTR

Previous close

$9.52

Today's open

$9.53

Day's range

$9.04 - $9.53

52 week range

$7.27 - $15.93

Profile about AVTR

CEO

Emmanuel Ligner

Employees

13500

Headquarters

Radnor, PA

Exchange

New York Stock Exchange

Shares outstanding

682755402

Issue type

Common Stock

AVTR industries and sectors

Healthcare

Biotechnology & Life Sciences

News on AVTR

Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?

Avantor (AVTR) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • May 29, 2026

news preview

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

AVTR's product breadth, digital upgrades and new pharma wins support growth, though VWR Distribution & Services remains a challenge.

news source

Zacks Investment Research • May 29, 2026

news preview

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.

news source

PRNewsWire • May 19, 2026

news preview

The Broyhill Q1 2026 Portfolio Strategy And Positioning

Valvoline was Broyhill's largest contributor in the quarter, as the underlying unit economics are intact, while unit growth, service mix, and price continue moving in the same direction. Honeywell management accelerated the aerospace spin-off to the end of June, leaving behind a pure-play automation business that Broyhill believes is worth meaningfully more than the whole. Large pharma is structurally reliant on IQVIA's clinical trial architecture and proprietary data assets, and Broyhill thinks it is highly unlikely that AI can automate away the FDA approval process.

news source

Seeking Alpha • May 15, 2026

news preview

Diamond Hill Capital Management Mid Cap Strategy Q1 2026 Drivers And Decisions

Regal Rexnord outperformed in Q1 as the company reported strong orders for a new data center product, which should support solid revenue growth in 2027. Diamond Hill initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given a constructive long-term outlook for US natural gas. Carrier Global is now a focused, high-quality business that Diamond Hill believes is in an excellent position to continue to gain market share and improve margins long-term.

news source

Seeking Alpha • May 8, 2026

news preview

Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity

We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated a position in Antero Resources, a natural gas exploration and production company, to gain exposure given our constructive long-term outlook for US natural gas. We exited our position in First Advantage, a leader in the background check space, to pursue other opportunities with less macro exposure and AI-disruption concerns.

news source

Seeking Alpha • May 7, 2026

news preview

Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible

Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks.

news source

Seeking Alpha • Apr 30, 2026

news preview

Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline

AVTR benefits from stable Q1 revenues and improving demand trends, though margin pressure and volume softness weigh on profitability.

news source

Zacks Investment Research • Apr 30, 2026

news preview

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • Apr 29, 2026

news preview

Avantor® Reports First Quarter 2026 Results

Net sales of $1,581 million Net income of $43 million; Adjusted EBITDA of $219 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 Operating cash flow of $59 million; free cash flow of $25 million Reaffirms FY 2026 guidance RADNOR, Pa., April 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first fiscal quarter ended March 31, 2026.

news source

PRNewsWire • Apr 29, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Avantor Inc.

Open an M1 investment account to buy and sell Avantor Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AVTR on M1